| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Apr―22 |
The clinical and immunological features of alopecia areata following SARS-CoV-2 infection or COVID-19 vaccines |
Shiqi Fu, Xiuzu Song |
| 2 |
[GO] |
2023―Aug―21 |
ORF6, a repressor of the MHC class I pathway: New molecular target for SARS-CoV-2 drug discovery? |
Baohui Zhu, Ryota Ouda, Paul de Figueiredo, Koichi S Kobayashi |
| 3 |
[GO] |
2023―May―24 |
Virus-induced senescence: A therapeutic target to mitigate severe progression of SARS-COV-2 |
Mani Iyer Prasanth, James Michael Brimson, Tewin Tencomnao |
| 4 |
[GO] |
2022―Jan―24 |
Ramatroban for chemoprophylaxis and treatment of COVID-19: David takes on Goliath |
Kate C. Chiang, John G. Rizk, Deanna J. Nelson, Lakshmanan Krishnamurti, Selvakumar Subbian, John D. Imig, Imran Khan, Srinivasa T. Reddy, Ajay Gupta |
| 5 |
[GO] |
2021―Nov―25 |
Alternative antigen to defuse SARS-CoV-2 delta variant and its ensuing evolutionary lineage |
Ariel Fernández Stigliano |
| 6 |
[GO] |
2021―Nov―11 |
Correspondence regarding: TLR4 as a therapeutic target for respiratory and neurological complications of SARS-CoV-2 |
Dhriti Kaushik, Ranjana Bhandari, Anurag Kuhad |
| 7 |
[GO] |
2021―Nov―09 |
Role of hemagglutinin esterase in replication of SARS-CoV-2 |
Milad Zandi, Saber Soltani, Parastoo Hosseini |
| 8 |
[GO] |
2021―Jul―13 |
Enteroviruses and coronaviruses: Similarities and therapeutic targets |
Varpu Marjomäki, Kerttu Kalander, Maarit Hellman, Perttu Permi |
| 9 |
[GO] |
2021―Jul―08 |
Drugs that offer the potential to reduce hospitalization and mortality from SARS-CoV-2 infection: The possible role of the Sigma-1 receptor and autophagy |
James Michael Brimson, Mani Iyer Prasanth, Dicson Sheeja Malar, Sirikalaya Brimson, Premrutai Thitilertdecha, Tewin Tencomnao |
| 10 |
[GO] |
2021―Jul―07 |
Neuromodulatory effects of SARS-CoV2 infection: Possible therapeutic targets |
Sonali Kumar, Ozasvi R Shanker, Neeraj Kumari, Manjari Tripathi, P Sarat Chandra, Aparna Banerjee Dixit, Jyotirmoy Banerjee |
| 11 |
[GO] |
2021―Apr―17 |
TLR4 as a therapeutic target for respiratory and neurological complications of SARS-CoV-2 |
Dhriti Kaushik, Ranjana Bhandari, Anurag Kuhad |
| 12 |
[GO] |
2020―Sep―17 |
Therapeutic antibodies and fusion inhibitors targeting the spike protein of SARS-CoV-2 |
Shibo Jiang, Xiujuan Zhang, Lanying Du |
| 13 |
[GO] |
2020―Jun―27 |
The cytokine storm of COVID-19: a spotlight on prevention and protection |
Lucie Pearce, Sean M. Davidson, Derek M. Yellon |
